Biondo Investment Advisors’s Transmedics TMDX Stock Holding History

Biondo Investment Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.76M	Buy	57,970 +755	+1%	+$98.5K	0.74%	38
2025 Q4	$6.96M	Sell	57,215 -1,160	-2%	-$146K	0.84%	36
2025 Q3	$6.55M	Sell	58,375 -105	-0.2%	-$12.3K	0.82%	37
2025 Q2	$7.84M	Buy	58,480 +410	+0.7%	+$45K	1.03%	34
2025 Q1	$3.91M	Buy	58,070 +4,620	+9%	+$318K	0.55%	42
2024 Q4	$3.33M	Sell	53,450 -1,625	-3%	-$151K	0.46%	42
2024 Q3	$8.65M	Buy	55,075 +1,670	+3%	+$257K	1.19%	35
2024 Q2	$8.04M	Buy	+53,405	New	+$6.41M	1.19%	34

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Biondo Investment Advisors's TMDX Position: Q1 2026 in Review

Biondo Investment Advisors increased its Transmedics (TMDX) stake by 1.3% in Q1 2026, buying an estimated $98.5K and bringing the position to 57,970 shares worth $5.76M. The position accounts for 0.74% of the portfolio, ranked #38.

Biondo Investment Advisors first reported a position in TMDX in Q2 2024 and has held it in 8 quarters since. The position peaked at $8.65M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Biondo Investment Advisors held 57,970 shares of Transmedics worth $5.76M as of Q1 2026.
Biondo Investment Advisors bought 755 Transmedics shares in Q1 2026, an estimated $98.5K.
Transmedics made up 0.74% of Biondo Investment Advisors's portfolio in Q1 2026, its #38 holding.
Biondo Investment Advisors first reported a position in Transmedics in Q2 2024 and has held it in 8 quarters since.
Biondo Investment Advisors's Transmedics position peaked at $8.65M in Q3 2024.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Biondo Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.